Status:
WITHDRAWN
Impact of Perioperative Anesthetic Management on Renal Cancer Progression.
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Perioperative Anesthetic
Renal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The relationship between perioperative drugs, including preoperative medications, anesthetics, and analgesics, and postoperative outcomes in cancer patients is a complex and evolving field of study. U...
Detailed Description
This retrospective study will investigate the association of perioperative drugs on short and long-term postoperative outcomes in patients undergoing kidney surgeries for renal cell carcinoma.
Eligibility Criteria
Inclusion
- Adult Participants (18 years of age or older)
- Participants having radical or partial nephrectomies with curative intent.
Exclusion
- Patients with distant metastatic disease and those with multiple (more than 1) primary tumors at the time of the nephrectomy
- Biopsies
- Participants who had radiofrequency or microwave ablations.
Key Trial Info
Start Date :
July 31 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2028
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06536244
Start Date
July 31 2020
End Date
September 1 2028
Last Update
August 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030